Ohio State University and Ohio University are creating a $35 million venture capital fund aimed at commercializing research that comes out of universities in the state.
California-based Dominion Ventures will be the fund’s general partner, according to a statement from the two universities. An official with Dominion wasn’t available for comment.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Ohio State plans to contribute $20 million to the fund and Ohio University pledged $15 million.
“We hope to move more innovations to the marketplace to cure disease, produce healthier food and advance alternative energy solutions,” said Roderick Davis, Ohio University’s president.
The fund plans to invest in research that emerges from other universities in the state as well as Ohio State and Ohio University.
More details on the fund are expected to be available next quarter.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Ohio State’s technology transfer program generated $1.9 million in licensing revenue in 2010, according to the annual survey from the Association of University Technology managers. OSU spent $756 million on research and created eight startups during the same year.
Ohio University’s numbers weren’t included in the survey.
